User profiles for Oluwaseun Falade-Nwulia

Oluwaseun Falade-Nwulia

Johns Hopkins University
Verified email at jhmi.edu
Cited by 2506

Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review

O Falade-Nwulia, C Suarez-Cuervo… - Annals of internal …, 2017 - acpjournals.org
Background: Rapid improvements in hepatitis C virus (HCV) therapy have led to the
approval of multiple oral direct-acting antiviral (DAA) regimens by the US Food and Drug …

Hepatitis C in Black Individuals in the US: A Review

O Falade-Nwulia, SM Kelly, S Amanor-Boadu… - JAMA, 2023 - jamanetwork.com
Importance In the US, the prevalence of hepatitis C virus (HCV) is 1.8% among people who
are Black and 0.8% among people who are not Black. Mortality rates due to HCV are 5.01/…

Understanding and addressing hepatitis C reinfection in the oral direct‐acting antiviral era

O FaladeNwulia, MS Sulkowski… - Journal of viral …, 2018 - Wiley Online Library
The availability of effective, simple, well‐tolerated oral direct‐acting antiviral ( DAA ) hepatitis
C regimens has raised optimism for hepatitis C virus ( HCV ) elimination at the population …

High hepatitis C cure rates among black and nonblack human immunodeficiency virus–infected adults in an urban center

O FaladeNwulia, C Sutcliffe, J Moon, G Chander… - Hepatology, 2017 - journals.lww.com
Hepatitis C virus (HCV) cure rates have been similar in patients with and without human
immunodeficiency virus (HIV) coinfection; however, in the ION‐4 study, black patients treated …

Hepatitis C treatment uptake among people who inject drugs in the oral direct‐acting antiviral era

O FaladeNwulia, RE Gicquelais… - Liver …, 2020 - Wiley Online Library
Background Increased uptake of hepatitis C virus (HCV) treatment among people who inject
drugs (PWID) will be critical to achieve HCV elimination goals. There are limited data on …

Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore

O Falade-Nwulia, R Irvin, A Merkow… - Journal of substance …, 2019 - Elsevier
Background Hepatitis C virus (HCV) infection is a major public health issue among people
who inject drugs (PWID) with prevalence of 50–80% in the United States. Effective, simple, …

Public health clinic‐based hepatitis C testing and linkage to care in baltimore

O FaladeNwulia, SH Mehta, J Lasola… - Journal of viral …, 2016 - Wiley Online Library
Testing and linkage to care are important determinants of hepatitis C virus ( HCV ) treatment
effectiveness. Public health clinics serve populations at high risk of HCV . We investigated …

Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infection

O Falade-Nwulia, EC Seaberg… - Clinical infectious …, 2012 - academic.oup.com
Background. It is not known whether chronic hepatitis B (CH-B) or chronic hepatitis C (CH-C)
carries a greater risk of liver-related mortality. This study compared rates of liver-related …

Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial

…, AF Luetkemeyer, O Falade-Nwulia… - The Lancet …, 2022 - thelancet.com
Background To achieve WHO targets for the elimination of hepatitis C virus (HCV) as a public
threat, an increased uptake of HCV treatment among people who inject drugs (PWID) is …

Incident hepatitis B virus infection in HIV-infected and HIV-uninfected men who have sex with men from pre-HAART to HAART periods: a cohort study

O Falade-Nwulia, EC Seaberg, AE Snider… - Annals of internal …, 2015 - acpjournals.org
Background: Men who have sex with men (MSM) are at high risk for hepatitis B virus (HBV)
infection. Data on the effect of highly active antiretroviral therapy (HAART) on incident HBV …